NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer

Published:2018-09-03 Issue:1 Volume:79 Page:44-53
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Chen Zhixiong¹,Jiang Qilong¹,Zhu Pingyu²,Chen Yanlin³,Xie Xuemei⁴,Du Zhongbo¹,Jiang Li¹,Tang Wei¹^ORCID

Affiliation:

1. Department of Urology; The First Affiliated Hospital of Chongqing Medical University; Chongqing P. R. China

2. Department of Urology; The Affiliated Hospital of North Sichuan Medical College,; Nanchong P. R. China

3. Department of Pathology; The First Affiliated Hospital of Chongqing Medical University; Chongqing P. R. China

4. Molecular and Pathological Diagnosis Center; Chongqing Medical University; Chongqing P. R. China

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23709/fullpdf

Reference39 articles.

1. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer;Heidenreich;Eur Urol,2014

2. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence;Revandkar;Nat Commun,2016

3. Notch Pathway Inhibition Using PF-03084014, a gamma-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer;Cui;Clin Cancer Res,2015

4. Activation of beta-catenin signaling in androgen receptor-negative prostate cancer cells;Wan;Clin Cancer Res,2012

5. WNT signalling in prostate cancer;Murillo-Garzon;Nat Rev Urol,2017

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model;2024-07-09

2. NPRL2 gene therapy induces effective antitumor immunity in KRAS/STK11 mutant anti-PD1 resistant metastatic non-small cell lung cancer (NSCLC) in a humanized mouse model;2024-07-09

3. RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway;Cell Death & Disease;2024-07-02

4. The Cytoprotective and Cytotoxic Functions of Autophagy in Response to mTOR Inhibitors;Frontiers in Bioscience-Landmark;2024-06-24

5. NPRL2 is required for proliferation of oncogenic Ras-transformed bronchial epithelial cells;Cell Division;2024-06-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3